You are here

clesrovimab

Sanofi starts shipping RSV drug early as rival nears market

Pharmaphorum

Mon, 06/9/25 - 10:53 am

Merck targets 2025 RSV season with antibody now under FDA review

BioPharma Dive

Wed, 12/18/24 - 11:09 am

Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study

Reuters

Thu, 10/17/24 - 08:39 pm

clinical trials

Merck claims late-stage study success for RSV antibody

BioPharma Dive

Tue, 07/23/24 - 11:36 am